Immunizations for Travel to Costa Rica & Panama in a 45-Year-Old Female with Rheumatoid Arthritis
For travel to Costa Rica and Panama, this patient should receive hepatitis A (with an extra priming dose if departure is imminent), typhoid, and ensure routine vaccinations are current, while avoiding live vaccines if she is on immunosuppressive therapy.
Critical Timing Consideration
- Start vaccinations 4-6 weeks before departure to ensure adequate immunity development 1
- If this patient is on immunosuppressive medications (DMARDs, biologics, or corticosteroids), she requires special vaccination timing considerations 2
Essential Travel-Specific Vaccines for Central America
Hepatitis A (Highest Priority)
- Hepatitis A vaccination is strongly recommended for travelers to Costa Rica and Panama due to foodborne and waterborne exposure risk 2, 1
- Critical caveat for RA patients on immunosuppression: A single dose does NOT provide adequate protection 2
- Give two doses of hepatitis A vaccine - either as a double dose or four weeks apart, followed by a booster at 6 months 2, 3
- If departure is imminent and she cannot receive two doses pre-travel, consider passive immunization with hepatitis A immunoglobulin 2
- Post-vaccination antibody titers should be checked to confirm seroconversion 2
Typhoid Fever
- Typhoid vaccination is recommended for travelers to Central America, especially those visiting smaller cities, rural areas, or consuming food from local markets 1, 4
- Use the inactivated (injectable) typhoid vaccine if she is immunosuppressed, NOT the oral live vaccine 2
Routine Vaccinations to Update
Tetanus-Diphtheria-Pertussis (Tdap)
- Update Tdap before travel 1
- RA patients show satisfactory immunogenicity to tetanus vaccination even on immunosuppressive drugs 2
Influenza
- Annual influenza vaccination is strongly recommended regardless of immunosuppressive therapy 2, 5
- For patients on immunosuppressive medications, high-dose or adjuvanted influenza vaccine is preferred over standard-dose 2
- If high-dose/adjuvanted vaccine is unavailable, give standard-dose rather than delaying 2
- If on methotrexate, consider holding it for 2 weeks after vaccination if disease activity allows 5
Pneumococcal
- Pneumococcal vaccination is strongly recommended for RA patients <65 years on immunosuppressive medications 2
- Follow CDC guidelines for PCV15 followed by PPSV23, or single-dose PCV20 2
Hepatitis B
- Consider hepatitis B vaccination if she may have sexual contact with new partners, receive medical/dental treatment, or have potential blood/bodily fluid exposure 1
- Note that RA patients on biologics may have insufficient humoral response to HBV vaccine 2
Vaccines to AVOID
Live Attenuated Vaccines
- Live attenuated vaccines should be avoided if she is on immunosuppressive therapy 2, 1
- This includes: oral typhoid, yellow fever (not required for Costa Rica/Panama), BCG, and live herpes zoster vaccine 2
- Yellow fever is NOT required for entry to Costa Rica or Panama 4
Medication-Specific Timing Considerations
If on Rituximab (B-cell depleting therapy)
- Ideally vaccinate BEFORE starting rituximab 2
- If already on rituximab, vaccinate at least 6 months after starting but 4 weeks before the next course 2
- Humoral responses are severely hampered 1-3 months after rituximab 2
If on TNF Inhibitors or Methotrexate
- Vaccinations can be administered during use of these medications 2
- Most patients develop protective antibody levels, though responses may be slightly reduced 2
If on Prednisone ≥20 mg Daily
- Administer influenza vaccination regardless of dose 5
- Consider deferring other non-live vaccinations until glucocorticoids are tapered to <20 mg daily 5
Additional Considerations
Rabies
- Consider rabies vaccination if she will be involved in outdoor activities, working with animals, or staying for extended periods 1
- Use inactivated rabies vaccine (safe in immunosuppressed patients) 1
Multiple Vaccine Administration
- Multiple vaccines can be administered simultaneously on the same day without reducing effectiveness 1, 5
Common Pitfalls to Avoid
- Failing to account for reduced vaccine efficacy in immunosuppressed patients - particularly for hepatitis A where a single dose is insufficient 2
- Giving live vaccines to immunosuppressed patients - verify immunosuppression status before any vaccination 2
- Not allowing adequate lead time - starting vaccinations <4 weeks before departure may not provide adequate immunity 1
- Assuming standard vaccination schedules apply - RA patients on immunosuppression require modified schedules for optimal protection 2, 3